# Allergopharma opens new biopharmaceutical production in Reinbek

Merck's allergy business Allergopharma opened a new biopharmaceutical production facility in Reinbek, Germany, representing a €42 million investment. The 6,000 m² factory includes a 2,000 m² glass cleanroom and will support global expansion of the allergies business.

- Type: Expansion
- Announced: 2017-03-04
- Where: Reinbek, near Hamburg, Germany
- Value: $44.5M (42.0M EUR)
- Starts operating: 4 Mar 2017
- Status: completed
- Products: allergen immunotherapy products
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)
- [Allergopharma](https://endata.com/companies/22631.md)

## Sources

- [cphi-online.com](https://www.cphi-online.com/news/allergopharma-opens-new-biopharmaceutical-production-in-reinbek/), 2017-03-04: "By this €42 million investment Merck is supporting the Reinbek site to expand the allergies business on a global scale."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.